From the Royal Free Perioperative Research Group, Royal Free NHS Foundation Trust, Anaesthetics Department, Hampstead, London, United Kingdom.
Exp Clin Transplant. 2021 Apr;19(4):339-344. doi: 10.6002/ect.2020.0422. Epub 2021 Mar 17.
Acute kidney injury is a significant cause of morbidity after orthotopic liver transplant. Early extubation after liver transplant may have a beneficial effect on postoperative renal function. This may be the result of reduction in vasopressor-mediated vasoconstriction used to counteract the hypotension associated with sedative use and the effects of positive-pressure ventilation. Previous studies explored advantages of early extubation after liver transplant but focused on resource usage rather than clinical benefit. This study was designed to determine the association between fast-track extubation and reduction in postoperative vasopressor requirement and whether this had any association with acute kidney injury incidence or renal replacement therapy requirement.
Data were collected from 144 orthotopic liver transplants. A propensity-matched case-control analysis was conducted on a subgroup of 33 patients who were fast-track extubated and with 33 propensity score-matched control patients who were not. The primary outcome was median days of postoperative vasopressor use, and secondary outcomes included incidence of acute kidney injury, renal replacement therapy requirement, and critical care admission duration.
The fast-track extubation group had a shorter postoperative vasopressor requirement (0 vs 2 days; P < .01) and a reduced need for renal replacement therapy (3% vs 21.2%; P = .05). Median critical care admission duration (3 vs 4 days; P = .03) and hospital admission duration (14 vs 19 days; P = .04) were shorter in the fast-track extubation group.
This is the first study to reveal a significant association between fast-track extubation and reduced postoperative vasopressor requirement. Additionally, this was associated with a trend toward reduced renal replacement requirement after liver transplant. It suggests that early extubation may not just be a resource benefit to an institution but may convey a clinical benefit to patients through a reduction in organ failure and requirement for organ support.
急性肾损伤是肝移植后发病率的重要原因。肝移植后早期拔管可能对术后肾功能有有益的影响。这可能是由于减少了血管加压剂介导的血管收缩,以对抗镇静药物使用引起的低血压和正压通气的影响。先前的研究探讨了肝移植后早期拔管的优势,但侧重于资源使用,而不是临床益处。本研究旨在确定快速拔管与减少术后血管加压药需求之间的关联,以及这种关联是否与急性肾损伤发生率或肾脏替代治疗需求有关。
从 144 例原位肝移植中收集数据。对 33 例快速拔管的患者进行倾向评分匹配的病例对照分析,并与 33 例未快速拔管的匹配对照患者进行比较。主要结果是术后血管加压药使用的中位数天数,次要结果包括急性肾损伤发生率、肾脏替代治疗需求和重症监护病房入院时间。
快速拔管组术后血管加压药需求时间较短(0 天与 2 天;P <.01),肾脏替代治疗需求减少(3%与 21.2%;P =.05)。快速拔管组重症监护病房入院时间(3 天与 4 天;P =.03)和住院时间(14 天与 19 天;P =.04)较短。
这是第一项揭示快速拔管与术后血管加压药需求减少之间存在显著关联的研究。此外,这与肝移植后肾脏替代治疗需求减少的趋势有关。这表明早期拔管不仅对机构有资源效益,而且可能通过减少器官衰竭和器官支持的需求,为患者带来临床益处。